Screening for chemical modulators for LRRK2.

Abstract excerpt

After the discovery of leucine-rich repeat kinase 2 (LRRK2) as a risk factor for sporadic Parkinson's disease (PD) and mutations in LRRK2 as a cause of some forms of familial PD, there has been substantial interest in finding chemical modulators of LRRK2 function. Most of the pathogenic mutations in LRRK2 are within the enzymatic cores of the protein; therefore, many screens have focused on finding chemical...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Discovery
• Share to High-Throughput Screening Assays
• Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2